Cargando…
Niclosamide encapsulated in mesoporous silica and geopolymer: A potential oral formulation for COVID-19
COVID-19 is a rapidly evolving emergency, for which there have been no specific medication found yet. Therefore, it is necessary to find a solution for this ongoing pandemic with the aid of advanced pharmaceutics. What is proposed as a solution is the repurposing of FDA approved drug such as niclosa...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400459/ https://www.ncbi.nlm.nih.gov/pubmed/34483712 http://dx.doi.org/10.1016/j.micromeso.2021.111394 |